Cherokee Pharmaceuticals has signed a new five-and-a-half-year commercial supply agreement with DuPont Applied BioSciences, a division of DuPont. Cherokee will manufacture a new product for DuPont using a DuPont proprietary fermentation process at its Riverside, PA facility. Initial production is scheduled to begin in late 2009. Over the term of the contract, production is expected to employ a significant proportion of Cherokee’s fermentation capacity. The manufacturing of this product ...